2007
DOI: 10.1016/j.tem.2006.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
40
0
3

Year Published

2007
2007
2016
2016

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(43 citation statements)
references
References 79 publications
0
40
0
3
Order By: Relevance
“…GH action is mediated through its binding to the GH receptor (GHR), a transmembrane protein that, upon ligand-induced dimerization, recruits intracellular JAK tyrosine kinases, specifically JAK2, which phosphorylate the GH receptor on tyrosine residues [15]. The phosphorylated GH receptor serves as a docking site for members of the signal transducer and activator of transcription (STAT) family, in particular STATs 1, 3, and 5, which are then tyrosine phosphorylated by the GHR-associated JAK kinase.…”
Section: The Gh-igf-i Axis In Modulating Growth and Organ Developmentmentioning
confidence: 99%
“…GH action is mediated through its binding to the GH receptor (GHR), a transmembrane protein that, upon ligand-induced dimerization, recruits intracellular JAK tyrosine kinases, specifically JAK2, which phosphorylate the GH receptor on tyrosine residues [15]. The phosphorylated GH receptor serves as a docking site for members of the signal transducer and activator of transcription (STAT) family, in particular STATs 1, 3, and 5, which are then tyrosine phosphorylated by the GHR-associated JAK kinase.…”
Section: The Gh-igf-i Axis In Modulating Growth and Organ Developmentmentioning
confidence: 99%
“…GHR engagement triggers activation of Janus kinase 2 (JAK2), STAT-3 and -5, and the mitogen-activated phosphatase kinase pathways but is also under the control of negative feedback (1,2). Such feedback control includes ubiquitin-dependent endocytosis of the GHR (3,4), transcriptionally induced SOCS (suppressors of cytokine signaling) proteins, PIAS (protein inhibitors of activated STATs) and signaling attenuation by protein-tyrosine phosphatases (PTPs).…”
Section: Growth Hormone (Gh)mentioning
confidence: 99%
“…Such feedback control includes ubiquitin-dependent endocytosis of the GHR (3,4), transcriptionally induced SOCS (suppressors of cytokine signaling) proteins, PIAS (protein inhibitors of activated STATs) and signaling attenuation by protein-tyrosine phosphatases (PTPs). Of particular interest among these factors are the PTPs, enzymes that, if validated, constitute drugable targets that may be exploited to treat growth-related disorders (2). The human PTP family comprises 37 "classical" PTPs (which exclusively dephosphorylate phosphotyrosine residues) plus 65 "dual specific phosphatases," most of which in addition dephosphorylate serine-and threonine-phosphate residues (5).…”
Section: Growth Hormone (Gh)mentioning
confidence: 99%
“…7 GH binds growth hormone receptors (GHRs) located on the cell surface in order to activate the intracellular signaling pathways involved in these processes. 8 GH plays an important role in the growth of cartilage, and GHRs are especially present in the mandibular condyle, 9,10 which plays a significant role in the growth and development of craniofacial morphology by regulating the angle and size of the morphology. 7 Dysfunctional mutations in the GHR gene cause Laron syndrome (GH insensitivity syndrome), which is associated with characteristic craniofacial morphology and short stature.…”
Section: Introductionmentioning
confidence: 99%